Stock SENZA SENZAGEN AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials SenzaGen AB

Equities

SENZA

SE0010219626

Biotechnology & Medical Research

Market Closed - Nasdaq Stockholm
Other stock markets
 06:59:49 2024-05-08 EDT 		5-day change 1st Jan Change
9.5 SEK +8.94% Intraday chart for SenzaGen AB +26.33% +30.49%
03-25 Senzagen Receives Follow-Up Order Worth SEK 0.8 Million from the Global Chemicals Leader CI
03-22 SenzaGen AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 236.5 290 176.1 210.9 - -
Enterprise Value (EV) 1 236.5 290 160.1 202.9 201.9 186.9
P/E ratio -7.41 x -11.7 x -8 x -14.1 x -51.3 x 21.3 x
Yield - - - - - -
Capitalization / Revenue - - 3.53 x 3.12 x 2.3 x 1.74 x
EV / Revenue - - 3.21 x 3 x 2.2 x 1.54 x
EV / EBITDA - - -22.7 x -71.2 x 19.6 x 7.77 x
EV / FCF - - -7.9 x -20.3 x - 12.5 x
FCF Yield - - -12.7% -4.93% - 8.02%
Price to Book - - 2.6 x 3.91 x 4.23 x 3.53 x
Nbr of stocks (in thousands) 23,648 24,065 24,188 24,188 - -
Reference price 2 10.00 12.05 7.280 8.720 8.720 8.720
Announcement Date 22-02-11 23-02-16 24-02-14 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net sales 1 - - 49.87 67.55 91.65 121.1
EBITDA 1 - - -7.053 -2.85 10.3 24.05
EBIT 1 - - -14.97 -12.05 1.15 14.3
Operating Margin - - -30.01% -17.84% 1.25% 11.81%
Earnings before Tax (EBT) 1 - - -21.98 -15 -4 10
Net income 1 -31.35 -24.91 -22.1 -15 -4 10
Net margin - - -44.31% -22.21% -4.36% 8.26%
EPS 2 -1.350 -1.030 -0.9100 -0.6200 -0.1700 0.4100
Free Cash Flow 1 - - -20.26 -10 - 15
FCF margin - - -40.63% -14.8% - 12.39%
FCF Conversion (EBITDA) - - - - - 62.37%
FCF Conversion (Net income) - - - - - 150%
Dividend per Share - - - - - -
Announcement Date 22-02-11 23-02-16 24-02-14 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 S1 2023 S1 2023 S2 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 19.92 23.59 26.28 14.6 18.3 16.1 24.1
EBITDA 1 -9.075 - - -1.9 -0.3 -2.6 2.1
EBIT 1 -13.68 -8.832 -6.136 -3.5 -1.9 -4.2 0.5
Operating Margin -68.64% -37.44% -23.35% -23.97% -10.38% -26.09% 2.07%
Earnings before Tax (EBT) -13.44 - - - - - -
Net income -13.5 -12.3 - - - - -
Net margin -67.74% -52.15% - - - - -
EPS - -0.5100 - - - - -
Dividend per Share - - - - - - -
Announcement Date 22-08-18 23-08-24 24-02-14 - - - -
1SEK in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - -
Net Cash position 1 - - 16 8 9 24
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 - - -20.3 -10 - 15
ROE (net income / shareholders' equity) - - - - - 18.2%
ROA (Net income/ Total Assets) - - - - - -
Assets 1 - - - - - -
Book Value Per Share 2 - - 2.800 2.230 2.060 2.470
Cash Flow per Share - - - - - -
Capex 1 - - 3.81 2 3 4
Capex / Sales - - 7.64% 2.96% 3.27% 3.3%
Announcement Date 22-02-11 23-02-16 24-02-14 - - -
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for SenzaGen AB

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Bio Diagnostics & Testing

1st Jan change Capi.
SENZAGEN AB Stock SenzaGen AB
+26.65% 19.51M
EXACT SCIENCES CORPORATION Stock Exact Sciences Corporation
-16.96% 11.29B
GUARDANT HEALTH, INC. Stock Guardant Health, Inc.
-30.43% 2.29B
BGI GENOMICS CO., LTD. Stock BGI Genomics Co., Ltd.
-11.81% 2.23B
VERACYTE, INC. Stock Veracyte, Inc.
-23.56% 1.61B
MARAVAI LIFESCIENCES HOLDINGS, INC. Stock Maravai LifeSciences Holdings, Inc.
+36.79% 1.19B
SEEGENE, INC. Stock Seegene, Inc.
-3.28% 752M
CAREDX, INC Stock CareDx, Inc
-12.67% 545M
ADAPTIVE BIOTECHNOLOGIES CORPORATION Stock Adaptive Biotechnologies Corporation
-36.53% 458M
CURIOX BIOSYSTEMS CO., LTD Stock Curiox Biosystems Co., Ltd
+13.72% 338M
Bio Diagnostics & Testing
  1. Stock Market
  2. Equities
  3. SENZA Stock
  4. Financials SenzaGen AB
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW